A103 and T311: Two new monoclonal antibodies against the Melan-A (MART-1) and tyrosinase antigens for use on formalin-fixed paraffin-embedded tissues Meeting Abstract


Authors: Jungbluth, A. A.; Chen, Y. T.; Stockert, E.; Iversen, K.; Coplan, K.; Tsang, S.; Busam, K.; Gerald, W.; Old, L. J.
Abstract Title: A103 and T311: Two new monoclonal antibodies against the Melan-A (MART-1) and tyrosinase antigens for use on formalin-fixed paraffin-embedded tissues
Meeting Title: 4th World Conference on Melanoma
Keywords: immunohistochemistry; primary tumor; metastasis; oncology; skin; malignant melanoma; dermatology; patient; clinical immunology; vitiligo; integumentary system; neoplastic disease; therapeutic method; integumentary system disease; diagnostic method; histochemical method; vaccine therapy; a103 monoclonal antibody; dermal nevi; formalin-fixed paraffin-embedded tissues; immunologic method; mart-1 antigen; melan-a antigen; normal subject; tyrosinase antigen; t311 monoclonal antibody
Journal Title: Melanoma Research
Volume: 7
Issue: Suppl. 1
Meeting Dates: 1997 Jun 10-14
Meeting Location: Sydney, Australia
ISSN: 0960-8931
Publisher: Lippincott Williams & Wilkins  
Date Published: 1997-01-01
Start Page: S127
Language: English
ACCESSION: BCI:BCI199799675923
DOI: 10.1097/00008390-199706001-00441
PROVIDER: biosis
PUBMED: 9239221
Notes: Meeting abstract: 441 -- Source: Biosis
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William L Gerald
    375 Gerald
  2. Achim Jungbluth
    458 Jungbluth
  3. Klaus J Busam
    689 Busam
  4. Lloyd J Old
    593 Old
  5. Keren Anne Coplan
    42 Coplan
  6. Yao-Tseng Chen
    83 Chen